Grace K. Dy

机构：Roswell Park Comprehensive Cancer Center · ORCID：0000-0002-5061-0072

发表论文 494 篇 · 总被引 13039 次 · h-index 45

代表论文

• Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer (2025 · Nature Medicine · 被引 39)
• Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV–GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors (2024 · Journal for ImmunoTherapy of Cancer · 被引 27)
• ZL-1310, a DLL3 ADC, in patients with extensive stage small cell lung cancer: Ph1 trial update. (2025 · Journal of Clinical Oncology · 被引 16)
• Immune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis (2024 · International Journal of Molecular Sciences · 被引 12)
• Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapy (2025 · Journal for ImmunoTherapy of Cancer · 被引 3)
• Fianlimab, a human lymphocyte activation gene‐3 monoclonal antibody, in combination with cemiplimab: Tumor‐specific expansion cohorts in advanced malignancies (2026 · Cancer · 被引 1)